Cam Patterson, MD, Executive DirectorCam Patterson, Executive Director, was a Harold Sterling Vanderbilt Scholar and studied Psychology and English at Vanderbilt University, graduating Summa Cum Laude. Dr. Patterson subsequently attended Emory University School of Medicine, graduating with induction in the Alpha Omega Alpha Honor Society, and completed a residency in Internal Medicine at Emory University Hospitals. He became Chief Resident at Grady Memorial Hospital at Emory University in 1992, supervising over 200 house officers in 4 hospitals. He completed 3 years of research fellowship under the guidance of Edgar Haber at the Harvard School of Public Health, developing an independent research program in vascular biology and angiogenesis, supported by an NIH fellowship. In 1996, he accepted his first faculty position at the University of Texas Medical Branch, and in 2000 Dr. Patterson was recruited to UNC-Chapel Hill to become the founding director of the UNC McAllister Heart Institute. In 2005, he also became the chief of the Division of Cardiology at UNC. Dr. Patterson is the Ernest and Hazel Craige Distinguished Professor of Cardiovascular Medicine, and he has been recognized at UNC with the Ruth and Phillip Hettleman Prize for Artistic and Scholarly Achievement. He is an Established Investigator of the American Heart Association and a Burroughs Wellcome Fund Clinical Scientist in Translational Research. He is a member of several editorial boards, including Circulation and Journal of Clinical Investigation, and is an elected member of the American Society of Clinical Investigation and the Association of University Cardiologists. Dr. Patterson maintains active research programs in the areas of angiogenesis and vascular development, cardiac hypertrophy, protein quality control, and translational genomics and metabolomics. He received his MBA from the UNC Kenan-Flagler School of Business in 2008.
MBA Kenan-Flagler Business School, University of North Carolina-Chapel Hill
MD Medicine, Emory University School of Medicine
BA Psychology/English, Vanderbilt University
Don Rose, Ph.D., DirectorDon Rose is the Director of UNC’s Carolina KickStart Program (formerly NC BioStart). Prior to that, he held senior leadership roles at a number of life science startups: Metabolon (metabolomics, RTP), Deerac Fluidics (nanoliter dispensing, Dublin), and DataCentric Automation (high-throughput crystallography, Nashville). Before that, he was a general partner with Catalysta Partners (now Hatteras Venture Partners), a seed stage venture fund specializing in information technology and biotechnology start-ups. During this time, Don was co-founder and CEO of Phase Bioscience, a biomaterials start-up, spun out of Duke University. Prior to Catalysta, he was co-founder and VP of Research and Development for Cartesian Technologies, a leader in instrumentation for DNA microarrays and nanoliter dispensing. Prior to Cartesian, Dr. Rose was a research scientist at Glaxo Wellcome (now GSK) where he developed and promoted a number of technologies in bioanalytical chemistry, combinatorial chemistry and high-throughput screening. Prior to GW, Dr. Rose developed various aspects of capillary electrophoreses instrumentation at Hewlett-Packard Laboratories. Dr. Rose received his Ph.D. in Analytical Chemistry and BS in Nutrition from the University of North Carolina. He has published eight papers, two book chapters, and holds six US patents.
BSPH Nutrition, University of North Carolina—Chapel Hill
Ph.D. Chemistry, University of North Carolina—Chapel Hill
Andy Kant, Assistant DirectorAndrew initially became interested in bioentrepreneurship during graduate school, as an alternative to traditional career paths. Subsequently he co-founded the 501(c)3 non-profit Carolina Student Biotechnology Network, helping students to learn more about career alternatives focused on entrepreneurship. Later in his schooling, he interned at UNC’s Office of Technology Development and co-authored a paper on entrepreneurship education. Prior to graduate school, Andrew was a fellow at the FDA’s National Center for Toxicological Research and Whitney Laboratory, University of Florida.
BS Biology, University of Massachusetts-Dartmouth
MS Toxicology, University of North Carolina—Chapel Hill
Ricky Spero, FellowDr. Richard Chasen Spero is a co-founder of Rheomics Inc. and leads its product development. As a doctoral student at UNC, Dr. Spero worked with his co-founders, Professors Richard Superfine and Russell Taylor, to design and use tools for experimental biophysics. Today he uses his expertise in nanoscale manipulation and high throughput imaging to define the revolutionary instrumentation Rheomics will bring to market. As part of his graduate work, Dr. Spero also invented techniques for blood clot characterization that are now in the Rheomics patent portfolio. Dr. Spero uses both this technical knowledge and customer experience to ensure that Rheomics products are the easiest and most effective solutions for automated microscopy and biological mechanics measurements.